Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack

Yongjun Wang and colleagues discuss recent evidence for using dual antiplatelet therapy to reduce recurrence of stroke or transient ischaemic attack

[1]  S. Johnston,et al.  Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack. , 2016, The New England journal of medicine.

[2]  J. Grotta.  Antiplatelet Therapy after Ischemic Stroke or TIA. , 2018, The New England journal of medicine.

[3]  Hao Li,et al.  Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial , 2016, Stroke and Vascular Neurology.

[4]  Hao Li,et al.  Dual Antiplatelet Therapy in Transient Ischemic Attack and Minor Stroke With Different Infarction Patterns: Subgroup Analysis of the CHANCE Randomized Clinical Trial , 2018, JAMA neurology.

[5]  Tammy Hoffmann,et al.  Clinical Guidelines for Stroke Management 2010 , 2010 .

[6]  K. Butcher,et al.  Canadian Stroke Best Practice Recommendations for Acute Stroke Management: Prehospital, Emergency Department, and Acute Inpatient Stroke Care, 6th Edition, Update 2018 , 2018, International journal of stroke : official journal of the International Stroke Society.

[7]  S. Johnston,et al.  Genetic Polymorphisms and Clopidogrel Efficacy for Acute Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis , 2017, Circulation.

[8]  C. Coffey,et al.  Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. , 2012, The New England journal of medicine.

[9]  G. Guyatt,et al.  Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline , 2018, British Medical Journal.

[10]  Liping Liu,et al.  Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. , 2013, The New England journal of medicine.

[11]  R. Conwit,et al.  Clopidogrel and Aspirin in Acute Ischemic Stroke and High‐Risk TIA , 2018, The New England journal of medicine.

[12]  김용권,et al.  뇌졸중 환자의 임상적 검사NIHSS(National Institutes of Health Stroke Scale)와 기능적 예후와의 상관관계 , 2002 .

[13]  Ming Liu,et al.  2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack , 2017, International journal of stroke : official journal of the International Stroke Society.

[14]  M. Wintermark,et al.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2013, Stroke.

[15]  S. Kasner,et al.  Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial , 2017, The Lancet Neurology.

[16]  S. Johnston,et al.  Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack. , 2016, The New England journal of medicine.

[17]  R. Conwit,et al.  The Secondary Prevention of Small Subcortical Strokes (SPS3) Study , 2011, International journal of stroke : official journal of the International Stroke Society.

[18]  G. Guyatt,et al.  Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis , 2018, British medical journal.

[19]  Yilong Wang,et al.  Dual versus mono antiplatelet therapy for acute non-cardioembolic ischaemic stroke or transient ischaemic attack: a systematic review and meta-analysis , 2018, Stroke and Vascular Neurology.

[20]  H. H. Jensen,et al.  Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial , 2017, The Lancet.